Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
The Body Covers:
The 4th International AIDS Malignancy Conference,
National Institutes of Health Campus, Bethesda, Maryland

May 16-18, 2000


M. Wayne Saville, M.D.
M. Wayne Saville, M.D.
HIV infection carries with it a high susceptibility to certain cancers, most notably, Kaposi's sarcoma (KS) and Hodgkin's and non-Hodgkin's lymphoma. At the 4th International AIDS Malignancy Conference, sponsored by the National Cancer Institute, the latest findings on malignancies in AIDS, transplantation and other types of immune deficiencies were presented. Covering this conference for The Body was M. Wayne Saville, M.D. from the University of California-San Diego. Dr. Saville has done extensive research on AIDS-related cancers, specifically Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma.

Funding for this conference coverage at The Body was provided, in part, by an unrestricted educational grant from Ligand Pharmaceuticals.


Conference Summaries


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement